INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 2 filers reported holding INSMED INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,664 | +19.7% | 343,110 | 0.0% | 0.12% | +26.9% |
| Q2 2023 | $7,240 | +23.8% | 343,110 | 0.0% | 0.09% | +16.2% |
| Q1 2023 | $5,850 | -14.7% | 343,110 | 0.0% | 0.08% | -12.1% |
| Q4 2022 | $6,855 | -99.9% | 343,110 | 0.0% | 0.09% | -10.8% |
| Q3 2022 | $7,391,000 | +9.2% | 343,110 | 0.0% | 0.10% | +20.0% |
| Q2 2022 | $6,766,000 | -16.1% | 343,110 | 0.0% | 0.08% | -3.4% |
| Q1 2022 | $8,063,000 | -13.7% | 343,110 | 0.0% | 0.09% | 0.0% |
| Q4 2021 | $9,346,000 | -1.1% | 343,110 | 0.0% | 0.09% | -9.3% |
| Q3 2021 | $9,449,000 | -3.2% | 343,110 | 0.0% | 0.10% | -4.0% |
| Q2 2021 | $9,765,000 | -16.4% | 343,110 | 0.0% | 0.10% | -11.4% |
| Q1 2021 | $11,686,000 | -8.4% | 343,110 | -10.4% | 0.11% | -10.9% |
| Q4 2020 | $12,754,000 | -10.4% | 383,110 | -13.5% | 0.13% | -20.0% |
| Q3 2020 | $14,242,000 | +16.7% | 443,110 | 0.0% | 0.16% | +12.7% |
| Q2 2020 | $12,203,000 | +71.8% | 443,110 | 0.0% | 0.14% | +43.4% |
| Q1 2020 | $7,103,000 | -32.9% | 443,110 | 0.0% | 0.10% | -21.4% |
| Q4 2019 | $10,581,000 | +35.4% | 443,110 | 0.0% | 0.13% | +27.3% |
| Q3 2019 | $7,816,000 | -22.3% | 443,110 | +12.7% | 0.10% | -20.8% |
| Q2 2019 | $10,064,000 | +206.1% | 393,110 | +247.5% | 0.12% | +197.6% |
| Q1 2019 | $3,288,000 | +121.6% | 113,110 | 0.0% | 0.04% | +100.0% |
| Q4 2018 | $1,484,000 | -69.5% | 113,110 | -53.0% | 0.02% | -66.1% |
| Q3 2018 | $4,866,000 | -49.9% | 240,642 | -41.4% | 0.06% | -54.1% |
| Q2 2018 | $9,719,000 | +15.8% | 410,954 | +10.3% | 0.14% | +4.7% |
| Q1 2018 | $8,392,000 | -31.3% | 372,662 | -4.9% | 0.13% | -27.1% |
| Q4 2017 | $12,223,000 | -12.5% | 392,007 | -12.4% | 0.18% | -10.6% |
| Q3 2017 | $13,964,000 | +475.1% | 447,429 | +216.3% | 0.20% | +435.1% |
| Q2 2017 | $2,428,000 | +13.2% | 141,471 | +15.5% | 0.04% | +2.8% |
| Q1 2017 | $2,144,000 | – | 122,450 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,799,225 | $40,519,000 | 16.80% |
| Foresite Capital Management II, LLC | 967,636 | $21,791,000 | 7.25% |
| Palo Alto Investors LP | 7,159,590 | $161,234,000 | 6.90% |
| Asymmetry Capital Management, L.P. | 162,185 | $3,652,000 | 4.57% |
| NEXTHERA CAPITAL LP | 918,523 | $20,685,000 | 3.41% |
| Redmile Group, LLC | 2,166,362 | $48,786,000 | 1.88% |
| Orbimed Advisors | 2,927,891 | $65,936,000 | 0.82% |
| Rock Springs Capital Management LP | 825,000 | $18,579,000 | 0.79% |
| Bellevue Group AG | 334,489 | $7,533,000 | 0.75% |
| EMERALD ADVISERS, LLC | 726,946 | $16,371,000 | 0.66% |